statistics

1. Clinical significance
In medicine and psychology, clinical significance is the practical importance of a treatment effect—whether it
has a real genuine, palpable, noticeable effect on daily life.[1]
Types of significance
Statistical significance
Practical significance
Specific usage
Calculation of clinical significance
Jacobson-Truax
Gulliksen-Lord-Novick
Edwards-Nunnally
Hageman-Arrindell
Hierarchical Linear Modeling (HLM)
See also
References
Statistical significance is used in hypothesis testing, whereby the null hypothesis (that there is no relationship
between variables) is tested.[2] A level of significance is selected (most commonly α = 0.05 or 0.01), which
signifies the probability of incorrectly rejecting a true null hypothesis.[2] If there is a significant difference
between two groups at α = 0.05, it means that there is only a 5% probability of obtaining the observed results
under the assumption that the difference is entirely due to chance (i.e., the null hypothesis is true); it gives no
indication of the magnitude or clinical importance of the difference.[3] When statistically significant results are
achieved, they favor rejection of the null hypothesis, but they do not prove that the null hypothesis is false.
Likewise, non-significant results do not prove that the null hypothesis is true; they also give no evidence of the
truth or falsity of the hypothesis the researcher has generated.[2] Statistical significance relates only to the
compatibility between observed data and what would be expected under the assumption that the null
hypothesis is true.
In broad usage, the "practical clinical significance" answers the question, how effective is the intervention or
treatment, or how much change does the treatment cause. In terms of testing clinical treatments, practical
significance optimally yields quantified information about the importance of a finding, using metrics such as
Contents
Types of significance
Statistical significance
Practical significance

2. effect size, number needed to treat (NNT), and preventive fraction.[4] Practical significance may also convey
semi-quantitative, comparative, or feasibility assessments of utility.
Effect size is one type of practical significance.[4][5] It quantifies the extent to which a sample diverges from
expectations.[6] Effect size can provide important information about the results of a study, and are
recommended for inclusion in addition to statistical significance. Effect sizes have their own sources of bias,
are subject to change based on population variability of the dependent variable, and tend to focus on group
effects, not individual changes.[5][7][8]
Although clinical significance and practical significance are often used synonymously, a more technical
restrictive usage denotes this as erroneous.[5] This technical use within psychology and psychotherapy not
only results from a carefully drawn precision and particularity of language, but it enables a shift in perspective
from group effects to the specifics of change(s) within an individual.
In contrast, when used as a technical term within psychology and psychotherapy, clinical significance yields
information on whether a treatment was effective enough to change a patient’s diagnostic label. In terms of
clinical treatment studies, clinical significance answers the question "Is a treatment effective enough to cause
the patient to be normal [with respect to the diagnostic criteria in question]?"
For example, a treatment might significantly change depressive symptoms (statistical significance), the change
could be a large decrease in depressive symptoms (practical significance- effect size), and 40% of the patients
no longer met the diagnostic criteria for depression (clinical significance). It is very possible to have a treatment
that yields a significant difference and medium or large effect sizes, but does not move a patient from
dysfunctional to functional.
Within psychology and psychotherapy, clinical significance was first proposed by Jacobson, Follette, and
Revenstorf [9] as a way to answer the question, is a therapy or treatment effective enough such that a client
does not meet the criteria for a diagnosis? Jacobson and Truax later defined clinical significance as “the extent
to which therapy moves someone outside the range of the dysfunctional population or within the range of the
functional population.”[10] They proposed two components of this index of change: the status of a patient or
client after therapy has been completed, and “how much change has occurred during the course of therapy.”
[10]
Clinical significance is also a consideration when interpreting the results of the psychological assessment of an
individual. Frequently, there will be a difference of scores or subscores that is statistically significant, unlikely
to have occurred purely by chance. However, not all of those statistically significant differences are clinically
significant, in that they do not either explain existing information about the client, or provide useful direction
for intervention. Differences that are small in magnitude typically lack practical relevance and are unlikely to
be clinically significant. Differences that are common in the population are also unlikely to be clinically
significant, because they may simply reflect a level of normal human variation. Additionally, clinicians look for
information in the assessment data and the client's history that corroborates the relevance of the statistical
difference, to establish the connection between performance on the specific test and the individual's more
general functioning.[11][12]
Just as there are many ways to calculate statistical significance and practical significance, there are a variety of
ways to calculate clinical significance. Five common methods are the Jacobson-Truax method, the Gulliksen-
Lord-Novick method, the Edwards-Nunnally method, the Hageman-Arrindell method, and hierarchical linear
Specific usage
Calculation of clinical significance

3. modeling.[5]
Jacobson-Truax is common method of calculating clinical significance. It involves calculating a Reliability
Change Index (RCI).[10] The RCI equals the difference between a participant’s pre-test and post-test scores,
divided by the standard error of the difference. Cutoff scores are established for placing participants into one of
four categories: recovered, improved, unchanged, or deteriorated, depending on the directionality of the RCI
and whether the cutoff score was met.
The Gulliksen-Lord-Novick method[13] is similar to Jacobson-Truax, except that it takes into account
regression to the mean. This is done by subtracting the pre-test and post-test scores from a population mean,
and dividing by the standard deviation of the population.[5]
The Edwards-Nunnally method[14] of calculating clinical significance is a more stringent alternative to the
Jacobson-Truax method.[15] Reliability scores are used to bring the pre-test scores closer to the mean, and then
a confidence interval is developed for this adjusted pre-test score. Confidence intervals are used when
calculating the change from pre-test to post-test, so greater actual change in scores is necessary to show clinical
significance, compared to the Jacobson-Truax method.
The Hageman-Arrindell[16] calculation of clinical significance involves indices of group change and of
individual change. The reliability of change indicates whether a patient has improved, stayed the same, or
deteriorated. A second index, the clinical significance of change, indicates four categories similar to those used
by Jacobson-Truax: deteriorated, not reliably changed, improved but not recovered, and recovered.
HLM involves growth curve analysis instead of pre-test post-test comparisons, so three data points are needed
from each patient, instead of only two data points (pre-test and post-test).[15] A computer program, such as
Hierarchical Linear and Nonlinear Modeling[17] is used to calculate change estimates for each participant.
HLM also allows for analysis of growth curve models of dyads and groups.
Medical statistics
Minimal clinically important difference
Cohen's h
1. Alan E. Kazdin (1999). "The Meanings and Measurement of Clinical Significance" (https://web.
Jacobson-Truax
Gulliksen-Lord-Novick
Edwards-Nunnally
Hageman-Arrindell
Hierarchical Linear Modeling (HLM)
See also
References

4. archive.org/web/20131106103031/http://homepage.psy.utexas.edu/homepage/class/Psy394Q/
Research%20Design%20Class/Assigned%20Readings/Clinical%20Trials/Kazdin99.pdf)
(PDF). Journal of Consulting and Clinical Psychology. 67 (3): 332–9.
CiteSeerX 10.1.1.595.9231 (https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.595.923
1). doi:10.1037/0022-006x.67.3.332 (https://doi.org/10.1037%2F0022-006x.67.3.332).
PMID 10369053 (https://pubmed.ncbi.nlm.nih.gov/10369053). Archived from the original (http://
homepage.psy.utexas.edu/homepage/class/Psy394Q/Research%20Design%20Class/Assigne
d%20Readings/Clinical%20Trials/Kazdin99.pdf) (PDF) on 6 November 2013. Retrieved
3 November 2013.
2. Polit, D. F.; Beck, C. T. (2012). Nursing Research: Generating Evidence for Nursing Practice
(9th ed.). Philadelphia: Wolters Klower/Lippincott Williams & Wilkins. ISBN 978-1-60547-782-
4.
3. Haase R.F.; Ellis M.V.; Ladany N. (1989). "Multiple Criteria for Evaluating the Magnitude of
Experimental Effects". Journal of Counseling Psychology. 36 (4): 511–516. doi:10.1037/0022-
0167.36.4.511 (https://doi.org/10.1037%2F0022-0167.36.4.511).
4. Shabbir, SH; Sanders, AE (September 2014). "Clinical significance in dementia research: a
review of the literature". American Journal of Alzheimer's Disease & Other Dementias. 29 (6):
492–7. doi:10.1177/1533317514522539 (https://doi.org/10.1177%2F1533317514522539).
PMID 24526758 (https://pubmed.ncbi.nlm.nih.gov/24526758).
5. Peterson, L. (2008). "Clinical" Significance: "Clinical" Significance and "Practical" Significance
are NOT the Same Things. Online Submission, Paper presented at the Annual Meeting of the
Southwest Educational Research Association (New Orleans, LA, Feb 7, 2008).
6. Vacha-Hasse, T., Nilsson, J.E., Reetz, ., Lance, T.S., & Thompson, B. (2000). Reporting
practices and APA editorial policies regarding statistical significance and effect size. Theory &
Psychology, 10, 413-425.
7. Cohen, J. (1997). The earth is round (p. 05). The American Psychologist, 49 (12), 997-1003.
8. Wilkinson L., APA , Inference Statistical (1999). "Statistical methods in psychology journals:
Guidelines and explanations". American Psychologist. 54 (8): 594–604. doi:10.1037/0003-
066x.54.8.594 (https://doi.org/10.1037%2F0003-066x.54.8.594).
9. Jacobson, N.S., Follette, W.C., and Revenstorf, D. (1984). Psychotherapy outcome research:
Methods for reporting variability and evaluating clinical significance. Behavior Therapy, 15(4).
10. Jacobson N.; Truax P. (1991). "Clinical significance: A statistical approach to defining
meaningful change in psychotherapy research". Journal of Consulting and Clinical
Psychology. 59 (1): 12–19. doi:10.1037/0022-006x.59.1.12 (https://doi.org/10.1037%2F0022-0
06x.59.1.12). S2CID 28125243 (https://api.semanticscholar.org/CorpusID:28125243).
11. Sattler JM (2008). Assessment of children: Cognitive foundations (5/e). San Diego: Sattler
Publications. ISBN 978-0-9702671-6-0
12. Kaufman, Alan S.; Lichtenberger, Elizabeth (2006). Assessing Adolescent and Adult
Intelligence (3rd ed.). Hoboken (NJ): Wiley. ISBN 978-0-471-73553-3. Lay summary (http://ww
w.wiley.com/WileyCDA/WileyTitle/productCd-0471735531.html) (22 August 2010).
13. Hsu L. M. (1999). "The comparison of three methods of identifying reliable and clinically
significant client changes: commentary on Hageman and Arrindell". Behaviour Research and
Therapy. 37 (12): 1195–1202. doi:10.1016/S0005-7967(99)00033-9 (https://doi.org/10.1016%2
FS0005-7967%2899%2900033-9). PMID 10596465 (https://pubmed.ncbi.nlm.nih.gov/1059646
5).
14. Speer D. C.; Greenbaum P. E. (1995). "Five methods for computing significant individual client
change and improvement rates: Support for an individual growth curve approach". Journal of
Consulting and Clinical Psychology. 63 (6): 1044–1048. doi:10.1037/0022-006x.63.6.1044 (htt
ps://doi.org/10.1037%2F0022-006x.63.6.1044). PMID 8543708 (https://pubmed.ncbi.nlm.nih.go
v/8543708).

5. Retrieved from "https://en.wikipedia.org/w/index.php?title=Clinical_significance&oldid=969254403"
This page was last edited on 24 July 2020, at 09:16 (UTC).
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this
site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia
Foundation, Inc., a non-profit organization.
15. Peterson, L. (2008). "Clinical" Significance: "Clinical" Significance and "Practical" Significance
are NOT the Same Things. Online Submission, Paper presented at the Annual Meeting of the
Southwest Educational Research.
16. Hageman W. J.; Arrindell W. A. (1999). "Establishing clinically significant change: increment of
precision and the distinction between individual and group level of analysis". Behaviour
Research and Therapy. 37 (12): 1169–1193. doi:10.1016/s0005-7967(99)00032-7 (https://doi.o
rg/10.1016%2Fs0005-7967%2899%2900032-7). PMID 10596464 (https://pubmed.ncbi.nlm.nih.
gov/10596464).
17. "SSI - Scientific Software International, Inc" (https://web.archive.org/web/20090602193811/htt
p://www.ssicentral.com/hlm/index.html). Archived from the original (http://www.ssicentral.com/hl
m/index.html) on 2 June 2009. Retrieved 19 July 2009.